Serum relaxin-2 as a novel biomarker for prostate cancer

Br J Biomed Sci. 2018 Jul;75(3):145-148. doi: 10.1080/09674845.2018.1424499. Epub 2018 Mar 7.

Authors

Y Xu¹, Q Yu², Y Liu¹

Affiliations

¹ a Department of Urology , The Central Hospital of Linyi , Yishui , China.
² b Department of Urology , The Affiliated Hospital of Qingdao University , Qingdao , China.

PMID: 29513121
DOI: 10.1080/09674845.2018.1424499

No abstract available

Keywords: Relaxin-2; prostate cancer; prostate-specific antigen.

MeSH terms

Adult
Aged
Biomarkers, Tumor / blood*
Disease-Free Survival
Humans
Hyperplasia / blood*
Hyperplasia / pathology
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasms / blood
Neoplasms / pathology
Prostate-Specific Antigen / blood
Prostatic Neoplasms / blood*
Prostatic Neoplasms / pathology
Relaxin / blood*

Substances

Biomarkers, Tumor
RLN2 protein, human
Relaxin
Prostate-Specific Antigen